Clinical trial
Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients…
NCT00286130 · Central European Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00286130 |
|---|---|
| Title | Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer |
| Official title | A Randomised, Open-label Phase II Study Evaluating the Efficacy and Safety of Folfox6 + Cetuximab as First-line Therapy in Patients With Metastatic Colorectal Cancer |
| Lead sponsor | Central European Cooperative Oncology Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Cetuximab, Oxaliplatin, Leucovorin, 5FU, Irinotecan, FOLFOX 6, FOLFIRI |
| Enrollment | 150 |
| Start date | Jul 1, 2005 |
| Completion | Oct 1, 2007 |
| First posted | Feb 3, 2006 |
| Last update posted | May 1, 2012 |
| Countries | Austria, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czechia, Hungary, Israel, Portugal, Romania, Slovakia, Slovenia and 1 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: